Order Article Reprints

Maciel e Silva AT, Maia ALC, Silva JdO, Miranda SEM, Cantini TS, de Barros ALB, Soares DCF, de Magalhães MTQ, Alves RJ, Ramaldes GA. In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole. Pharmaceutics. 2023; 15(12):2751. https://doi.org/10.3390/pharmaceutics15122751

Maciel e Silva, Aline Teixeira, Ana Luiza Chaves Maia, Juliana de Oliveira Silva, Sued Eustáquio Mendes Miranda, Talia Silva Cantini, Andre Luis Branco de Barros, Daniel Crístian Ferreira Soares, Mariana Torquato Quezado de Magalhães, Ricardo José Alves, and Gilson Andrade Ramaldes. 2023. "In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole" Pharmaceutics 15, no. 12: 2751. https://doi.org/10.3390/pharmaceutics15122751

Maciel e Silva, A. T., Maia, A. L. C., Silva, J. d. O., Miranda, S. E. M., Cantini, T. S., de Barros, A. L. B., Soares, D. C. F., de Magalhães, M. T. Q., Alves, R. J., & Ramaldes, G. A. (2023). In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole. Pharmaceutics, 15(12), 2751. https://doi.org/10.3390/pharmaceutics15122751